Trials / Withdrawn
WithdrawnNCT00262353
Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of the efficacy of dialysis by conventional dialysis versus Prometheus artificial hepatic system
Detailed description
After inclusion, patients will be dialysed with low-flux artificial kidneys. 1 week of dialysis exists of 3 days of dialysis. In week 4, day 2, patients will be treated once with the Prometheus artificial hepatic system or with high-flux dialysis. The other days low-flux kidneys will be used. Week 5 and 6 are a wash-out period. Week 7 is identical to week 4 but the other system than in week 4 is used. Blood samples are taken at regular moments in week 3, week 4 (day 2) and week 7 (day 2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dialysis with different artificial devices |
Timeline
- First posted
- 2005-12-06
- Last updated
- 2021-07-02
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00262353. Inclusion in this directory is not an endorsement.